ReviewCell transplantation

Therapeutic and Systemic Adverse Events of Immune Checkpoint Inhibitors Targeting the PD-1/PD-L1 axis for Clinical Management of NSCLC.

Jing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.